These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 19244046)

  • 1. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR imaging features of different renal cell carcinoma subtypes].
    Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.
    Kim JH; Bae JH; Lee KW; Kim ME; Park SJ; Park JY
    Urology; 2012 Oct; 80(4):872-6. PubMed ID: 22854134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
    Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
    AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
    Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.
    Lu Q; Huang BJ; Xue LY; Fan PL; Wang WP
    AJR Am J Roentgenol; 2015 Sep; 205(3):W335-42. PubMed ID: 26295670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
    Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
    Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
    Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
    Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
    Pedrosa I; Alsop DC; Rofsky NM
    Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation.
    Chandarana H; Kang SK; Wong S; Rusinek H; Zhang JL; Arizono S; Huang WC; Melamed J; Babb JS; Suan EF; Lee VS; Sigmund EE
    Invest Radiol; 2012 Dec; 47(12):688-96. PubMed ID: 22996315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
    Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
    AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.